| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute lymphoblastic leukemia at the 2023 ASH meeting
|
Böhm, Alexandra
|
|
|
17 |
3 |
p. 168-171
|
artikel
|
| 2 |
β-adrenergic modulation of IL-6/gp130 and SOCS-1 in multiple myeloma: therapeutic strategy for stress induced-inflammatory response
|
Naiebi, Raika
|
|
|
17 |
3 |
p. 220-230
|
artikel
|
| 3 |
Advanced stage Hodgkinʼs lymphoma 2024—Update on first line treatment
|
Lehner, Barbara
|
|
|
17 |
3 |
p. 172-174
|
artikel
|
| 4 |
American Society of Hematology (ASH) update 2023—chronic lymphocytic leukemia
|
Nösslinger, Thomas
|
|
|
17 |
3 |
p. 175-177
|
artikel
|
| 5 |
Antibody–drug conjugates (ADCs) in lung cancer treatment
|
Wass, Romana E.
|
|
|
17 |
3 |
p. 198-203
|
artikel
|
| 6 |
Antibody–drug conjugates (ADC special)—part 2
|
Gampenrieder, Simon
|
|
|
17 |
3 |
p. 156-157
|
artikel
|
| 7 |
ASH 2023
|
Zojer, Niklas
|
|
|
17 |
3 |
p. 153
|
artikel
|
| 8 |
Emerging drugs in breast cancer: a focus on antibody–drug conjugates and novel treatment options in luminal disease
|
Bartsch, Rupert
|
|
|
17 |
3 |
p. 204-209
|
artikel
|
| 9 |
Emerging treatment strategies in chronic B-cell malignancies—News from ICML 2023
|
Bohn, Jan-Paul
|
|
|
17 |
3 |
p. 210-214
|
artikel
|
| 10 |
Importance of allogeneic stem cell transplantation in myelofibrosis
|
Hirschbühl, Klaus
|
|
|
17 |
3 |
p. 215-219
|
artikel
|
| 11 |
Liquid biopsy in breast cancer
|
Klocker, Eva Valentina
|
|
|
17 |
3 |
p. 194-197
|
artikel
|
| 12 |
Liquid profiling for patients with advanced cancer is ready for clinical integration
|
Hasenleithner, Samantha O.
|
|
|
17 |
3 |
p. 182-189
|
artikel
|
| 13 |
Molecular tumor board—editorial
|
Taghizadeh, Hossein
|
|
|
17 |
3 |
p. 154-155
|
artikel
|
| 14 |
Seminal vesicle metastasis from transverse colon adenocarcinoma: a unique case report
|
Arenas Hoyos, Juliana
|
|
|
17 |
3 |
p. 231-238
|
artikel
|
| 15 |
The molecular tumor board—a key element of precision oncology
|
Boos, Laura
|
|
|
17 |
3 |
p. 190-193
|
artikel
|
| 16 |
Trends in MDS and AML from ASH 2023
|
Pfeilstöcker, Michael
|
|
|
17 |
3 |
p. 178-181
|
artikel
|
| 17 |
15 years Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO): achievements and future perspectives
|
Valent, Peter
|
|
|
17 |
3 |
p. 158-167
|
artikel
|
Tijdschrift beschrijving